



Supplemental data on the investigation of potential interacting partners with the N-
terminus of CaV2.2 using the yeast two hybrid assay  
Methods 
Assays were carried out using the MATCHMAKER GAL4 yeast two hybrid kit (Clontech).  
Fragments of CaV2.2 within the first domain (amino acids 96-355, 180-225, 246-330), within the 
CaV2.2 N-terminus (1-95, 45-95, 56-95, 45-55), the CaV2.2 I-II loop (360-483), II-III loop (711-
1154), III-IV loop (1422-1476), C-terminus (1713-2339) and CaVβ1b were generated by PCR 
and subcloned in-frame into the vectors pACT2 and pAS2-1.  Plasmids were cotransformed into 
the yeast strain Y190 and transformants were selected by plating onto minimal selective dropout 
(SD) -Leu, -Trp agar.  Protein interactions were identified by re-streaking colonies onto SD -Leu, 
-Trp plates and carrying out colony-lift β-galactosidase assays according to the supplied 
protocol.  
Results 
We were unable to demonstrate any positive interactions between the N-terminus of CaV2.2 and 
the CaV2.2 I-II loop or CaV2.2 Dom I using the yeast two hybrid assay, in contrast to a previous 
study (1).  The CaV2.2 N-terminus was also truncated into smaller fragments (amino acids 45-95, 
56-95 and 45-55), none of which were shown to interact with CaV2.2 I-II linker.  We also made 
fusion proteins containing regions of domain I of the CaV2.2; the transmembrane domains 
(amino acids 96-355), the Domain IS4 trans-membrane region (180-225) and the p-loop region 
(246-330).  None of these were found to interact with the full-length (1-95) or the truncated (45-
95) N-terminus of CaV2.2 in this assay.  In addition, dimerization was investigated for each insert 
and found to be negative for all except Cav  1b.  All fragments were tested and found negative 
for autoactivation.  As a positive control in all assays, the CaV2.2 I-II loop was shown to interact 
with CaVβ1b, as described previously (2). Therefore we cannot identify a high affinity 
interaction of the CaV2.2 N-terminus with a particular peptide domain in the yeast two hybrid 
system, providing some support for the view that the N-terminus is more likely to interact in a 
complex binding pocket, involving multiple elements (Table 1). 2 
 
Table 1 
Summary of potential interactions examined by yeast two hybrid 








Cav  1b 
CaV2.2 N-term (1-95)  -  ND  ND  ND  - 
CaV2.2 I-II (360-483)  -  -  -  -  +++ 
CaV2.2 II-III (711-1154)  -  -  ND  ND  - 
CaV2.2 III-IV (1422-1476)  -  ND  ND  ND  - 
CaV2.2 C-term (1713-2339)  -  -  -  -  - 
CaV2.2 Dom I (96-355)  -  -  ND  ND  - 
CaV2.2 Is4 (180-225)  -  -  ND  ND  ND 
CaV2.2 I-p-loop (246-330)  -  -  ND  ND  ND 
Cav  1b  -  -  ND  ND  + 
 
Assays were carried out using the MATCHMAKER GAL4 yeast two hybrid kit (Clontech).  
Fragments of CaV2.2 within the first domain (amino acids 96-355, 180-225, 246-330), within the 
CaV2.2 N-terminus (1-95, 45-95, 56-95, 45-55), the CaV2.2 I-II loop (360-483), II-III loop (711-
1154), III-IV loop (1422-1476), C-terminus (1713-2339) and CaVβ1b were generated by PCR 
and subcloned in-frame into both vectors pACT2 and pAS2-1. Each combination of vectors was 
tested for each insert.  Protein interactions were identified by re-streaking colonies onto SD -Leu, 
-Trp plates and carrying out colony-lift β-galactosidase assays according to the supplied 
protocol.  For each combination, at least 8 colonies were tested, except for reactions involving 
CaV2.2 II-III and III-IV where 2-4 colonies were tested.  Interactions are indicated as +++ strong 
interaction ( -galactosidase assay develops in 30-60 min), + weaker interaction (1-6h), - negative 
interaction, ND: not determined.   
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Supplemental Figure 1 
Expression of GAPDH as a loading control 
 
 
Expression of GAPDH protein in untransfected tsA-201 cells (lane 1), when CaV2.2/ʱ2ʴ-1/β1b 
were expressed, alone (lane 2) and together with CaV2.2 N-terminus-CAAX (lane 3), or CaV2.2 
R52A, R54A-N-terminus-CAAX (lane 4).  The same amount of total protein was loaded for all 
samples on a gel, for accurate comparison between lanes.  These samples were the same as those 
illustrated in Fig. 6A. The primary Ab was a mouse anti-GAPDH monoclonal at 1:25,000. This 
experiment was replicated 3 times for other samples used for the bar chart in Fig. 6B, with 
identical results that GAPDH was unchanged. 
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